RIGI and neoplasm: revealed that circNDUFB2 suppresses NSCLC progression through destabilizing IGF2BPs, and it is also recognized by RIG-I to activate RIG-I-MAVS signaling cascades and enroll immune cells into the tumor microenvironment for triggering anti-tumor immunity (23).